Stock prices for Novo Nordisk fell by about 3% at market open after the Biden administration selected its revolutionary drugs for mandatory price negotiations.
President-elect Trump’s threat to tariff Denmark if it resists his acquisition plans for the island territory of Greenland could disrupt one export that is wildly popular in America:
Denmark is the latest in a series of countries that President-elect Donald Trump has threatened with tariffs — joining a list that includes the 26 other nations of the European Union, as well as Canada and Mexico.
Danish business leaders, including Novo Nordisk's CEO, met with Prime Minister Mette Frederiksen to address potential U.S.-Denmark trade conflicts over Greenland. This follows U.S. President-elect Trump's unclear stance on economic or military actions regarding Greenland.
As CNN previously reported, Danish officials fear Trump is much more serious about acquiring Greenland than he was in his first term. It’s also gotten the attention of officials at Novo Nordisk. “We will follow the situation closely,” a company ...
Putting tariffs on Denmark unless it cedes the island of Greenland could hurt access to a few key products, including popular medicines.
She said she had informed Greenland's Prime Minister Mute Egede ... The CEO of Danish obesity and diabetes drugmaker Novo Nordisk, Lars Fruergaard Jorgensen, will participate in the meeting ...
Denmark’s Prime Minister Mette Frederiksen has called the country’s business leaders to a meeting on Thursday after US President-elect Donald Trump last week threatened military or economic action such as tariffs to take control of Greenland.
U.S. trade dispute over Greenland, Danish Prime Minister Mette Frederiksen convenes top business leaders, including the CEO of Novo Nordisk, to strategize. The move follows Frederiksen's tense conversation with President-elect Donald Trump,
"Trump might forget about Greenland. But also, he might not. Nobody knows. He operates on whims," @anneapplebaum writes.
Eli Lilly (LLY 1.45%) began a roll in late 2020 that lasted almost four years. During that time, it became the world's largest healthcare company, with a market cap that topped $8